BIOMAT Database Logo BIOMAT Database Logo

5'-linked lipid-oligodeoxyridonucleotide derivatives as inhibitors of human immunodeficiency virus replication. 1996

S G Kim, and H Nakashima, and Y Shoji, and T Inagawa, and N Yamamoto, and Y Kinzuka, and K Takai, and H Takaku
Department of Industrial Chemistry, Chiba Institute of Technology, Japan.

The covalent attachment of a phospholipid moiety, bound to the 5'-ends of phosphodiester and phosphorothioate oligonucleotides (L-ODNs and LS-ODNs), was achieved using H-phosphonate chemistry, and the lipid-oligonucleotides were assayed for the inhibition of virus replication in HIV-1 infected MT-4 cells. In the anti-HIV activity test, lipid-phosphorothioate oligonucleotides showed higher anti-HIV activities than non-lipid-phosphorothioate oligonucleotides, at the low concentration of 0.04 microM. LS-ODNs can inhibit HIV-1 reverse transcriptase activity through interactions with the enzyme. We found that the covalent attachment of a phospholipid group to the 5'-end of the phosphorothioate oligonucleotide enhances its nonsequence specific anti-HIV activity.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009838 Oligodeoxyribonucleotides A group of deoxyribonucleotides (up to 12) in which the phosphate residues of each deoxyribonucleotide act as bridges in forming diester linkages between the deoxyribose moieties. Oligodeoxynucleotide,Oligodeoxyribonucleotide,Oligodeoxynucleotides
D010743 Phospholipids Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system. Phosphatides,Phospholipid
D002461 Cell Line, Transformed Eukaryotic cell line obtained in a quiescent or stationary phase which undergoes conversion to a state of unregulated growth in culture, resembling an in vitro tumor. It occurs spontaneously or through interaction with viruses, oncogenes, radiation, or drugs/chemicals. Transformed Cell Line,Cell Lines, Transformed,Transformed Cell Lines
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D012194 RNA-Directed DNA Polymerase An enzyme that synthesizes DNA on an RNA template. It is encoded by the pol gene of retroviruses and by certain retrovirus-like elements. EC 2.7.7.49. DNA Polymerase, RNA-Directed,RNA-Dependent DNA Polymerase,Reverse Transcriptase,RNA Transcriptase,Revertase,DNA Polymerase, RNA Directed,DNA Polymerase, RNA-Dependent,RNA Dependent DNA Polymerase,RNA Directed DNA Polymerase
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications

Related Publications

S G Kim, and H Nakashima, and Y Shoji, and T Inagawa, and N Yamamoto, and Y Kinzuka, and K Takai, and H Takaku
Betulinic acid derivatives as human immunodeficiency virus type 2 (HIV-2) inhibitors.
December 2009, Journal of medicinal chemistry,
S G Kim, and H Nakashima, and Y Shoji, and T Inagawa, and N Yamamoto, and Y Kinzuka, and K Takai, and H Takaku
1,3-Dihydroxyacridone derivatives as inhibitors of herpes virus replication.
February 2000, Antiviral research,
S G Kim, and H Nakashima, and Y Shoji, and T Inagawa, and N Yamamoto, and Y Kinzuka, and K Takai, and H Takaku
Phenylpropenamide derivatives as inhibitors of hepatitis B virus replication.
December 2000, Bioorganic & medicinal chemistry letters,
S G Kim, and H Nakashima, and Y Shoji, and T Inagawa, and N Yamamoto, and Y Kinzuka, and K Takai, and H Takaku
Synthesis and evaluation of beta-carboline derivatives as inhibitors of human immunodeficiency virus.
August 2010, Bioorganic & medicinal chemistry letters,
S G Kim, and H Nakashima, and Y Shoji, and T Inagawa, and N Yamamoto, and Y Kinzuka, and K Takai, and H Takaku
Triterpene derivatives that inhibit human immunodeficiency virus type 1 replication.
January 2011, Bioorganic & medicinal chemistry letters,
S G Kim, and H Nakashima, and Y Shoji, and T Inagawa, and N Yamamoto, and Y Kinzuka, and K Takai, and H Takaku
Oligonucleotides as inhibitors of human immunodeficiency virus.
June 1999, Current opinion in molecular therapeutics,
S G Kim, and H Nakashima, and Y Shoji, and T Inagawa, and N Yamamoto, and Y Kinzuka, and K Takai, and H Takaku
[Tandem bifunctional derivatives of short oligonucleotides--inhibitors of replication of the human immunodeficiency virus in cell culture].
January 1998, Molekuliarnaia biologiia,
S G Kim, and H Nakashima, and Y Shoji, and T Inagawa, and N Yamamoto, and Y Kinzuka, and K Takai, and H Takaku
5-Benzothiazole substituted pyrimidine derivatives as HCV replication (replicase) inhibitors.
May 2012, Bioorganic & medicinal chemistry letters,
S G Kim, and H Nakashima, and Y Shoji, and T Inagawa, and N Yamamoto, and Y Kinzuka, and K Takai, and H Takaku
Proteasome inhibitors act as bifunctional antagonists of human immunodeficiency virus type 1 latency and replication.
October 2013, Retrovirology,
S G Kim, and H Nakashima, and Y Shoji, and T Inagawa, and N Yamamoto, and Y Kinzuka, and K Takai, and H Takaku
Inhibition of human immunodeficiency virus type I replication by derivatives of gossypol.
December 1991, Pharmacological research,
Copied contents to your clipboard!